ICDD
Gémenos
About ICDD
ICDD creates diagnostic products and services to advance faster in the development of safe and effective drugs and personalized medicine in order to help patients get the best care possible. ICDD is a science-based company with activities focused on predictive toxicology and drug efficacy, as well as on diagnostics for CNS diseases (neurodegeneration). ICDD has developed proprietary technologies and innovative in vitro models used by our clients & partners to select the most efficient active compound in fee-for-service or industrial partnership contracts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $981.1K
- Funding stage: Seed
- Last round: Seed (Jul 2012)
- Website: icdd-sas.com
- Phone: +33 484 830 020
Industries & Categories
Biotechnology, Health Care, Life Science, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/icdd-838805 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.